Greenlight Guru has acquired SMART-TRIAL, the maker of an Electronic Data Capture (EDC) platform designed for medical devices and diagnostics. SMART-TRIAL offers a comprehensive data collection toolbox to comply with regulatory requirements on clinical data.
Shutterstock
Business negotiation, deal making or acquisition, merger vector concept. Two men shaking hands. Minimal design. Eps10 illustration.
Medtech clinical operations are different from other life science industries, and the SMART-TRIAL platform was designed with the sole purpose of addressing the exact challenges of the medical device and diagnostics industry. The platform has been fine-tuned in collaboration with manufacturers over the past nine years to ensure an ideal out-of-the-box fit with the clinical life cycle of devices.
Founded in 2013 by CEO Páll Jóhannesson, CCO Jón Ingi Bergsteinsson, and CTO Alex Bondo Andersen, the Denmark-based software company has helped over 100 companies easily and effectively collect high quality clinical data in compliance with industry regulations. The SMART-TRIAL platform has evolved into a market-leading complete data collection toolbox for Clinical Studies, Clinical Investigations, Clinical Performance Studies, Post-Market Clinical Follow-Up (PMCF), and Post-Market Performance Follow-Up (PMPF).
With all three SMART-TRIAL founders, as well as their team of 20+ employees set to join Greenlight Guru, the acquisition will enable the Indianapolis-based company to further expand its platform capabilities.
Greenlight Guru CEO, David DeRam, said: “60% of Greenlight Guru clients are currently running a clinical trial or are expecting to run one in the next 2 years, and over half of those are still using paper or Excel to manage the data. That is not only costly but extremely risky given the increasingly strict regulations on clinical data quality. Greenlight Guru and SMART-TRIAL have very similar missions and values, and we’re both exclusively focused on providing medtech companies with tailored software solutions to delightfully meet their needs. I know we can realise our shared goal much faster by combining forces.”
Páll Jóhannesson, CEO of SMART-TRIAL, added: “Greenlight Guru’s vision for the future of medtech is exactly what the industry needs, and we are very happy to be part of what will become the golden standard software platform for medtech companies around the globe. With the combined experience of Greenlight Guru and SMART-TRIAL and synergies between the platforms, we will be able to provide an offering for medtech of unprecedented quality and scale.”
The news follows Greenlight Guru’s recent acquisitions of CanvasGT, a software company enabling iterative medtech innovation and the future of the evolutionary design process, and Vertex Intelligence, a data science company developing custom artificial intelligence and machine learning solutions.
